New drug TG02 shows promise in early brain cancer trial
NCT ID NCT03224104
First seen Dec 12, 2025 · Last updated Jun 17, 2026 · Updated 23 times
Summary
This early-phase study tested a new drug called TG02 in 71 patients with aggressive brain cancers (anaplastic astrocytoma or glioblastoma). The goal was to find the safest dose when combined with either radiation or chemotherapy. The study included newly diagnosed elderly patients and those whose cancer had returned. Results help guide future research, but the drug is not yet proven as a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Assistance Publique - Hopitaux de Marseille - Hôpital de La Timone
Marseille, 13385, France
-
CHRU de Lille
Lille, France
-
CHU de Lyon - CHU Lyon - Hopital neurologique Pierre Wertheimer
Bron, 69677, France
-
Erasmus MC Cancer Institute - location Daniel den Hoed
Rotterdam, 3015, Netherlands
-
Klinikum Der J.W. Goethe Universitaet-Klinik und Poliklinik fur Neurochirurgie
Frankfurt, 60528, Germany
-
UniversitaetsSpital Zurich
Zurich, 8091, Switzerland
-
Universitaetskliniken Regensburg - Universitaetsklinikum Regensburg
Regensburg, 93053, Germany
-
Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH uniklinieken
Vienna, 1090, Austria
-
Universitaetsklinikum Bonn
Bonn, 53205, Germany
-
Universitaetsklinikum Heidelberg - UniversitaetsKlinikum Heidelberg - Head Hospital
Heidelberg, 69120, Germany
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.